NORGES BANK - ONCOMED PHARMACEUTICALS INC ownership

ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 85 filers reported holding ONCOMED PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORGES BANK ownership history of ONCOMED PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$190,000
+39.7%
182,3570.0%0.00%
Q4 2018$136,000
-64.9%
182,3570.0%0.00%
Q3 2018$387,000
-8.1%
182,3570.0%0.00%
Q2 2018$421,000
-27.4%
182,3570.0%0.00%
Q1 2018$580,000
-22.5%
182,3570.0%0.00%
Q4 2017$748,000
-9.2%
182,3570.0%0.00%
Q3 2017$824,000
+35.7%
182,3570.0%0.00%
Q2 2017$607,000
-63.9%
182,3570.0%0.00%
-100.0%
Q1 2017$1,680,000
+19.5%
182,3570.0%0.00%0.0%
Q4 2016$1,406,000
-29.4%
182,3570.0%0.00%0.0%
Q3 2016$1,991,000
-11.3%
182,3570.0%0.00%0.0%
Q2 2016$2,245,000
+21.7%
182,3570.0%0.00%0.0%
Q1 2016$1,844,000
-55.1%
182,3570.0%0.00%
-50.0%
Q4 2015$4,110,000
+35.9%
182,3570.0%0.00%0.0%
Q3 2015$3,025,000
-26.3%
182,3570.0%0.00%0.0%
Q2 2015$4,103,000
-12.7%
182,3570.0%0.00%0.0%
Q1 2015$4,701,000
+18.5%
182,3570.0%0.00%0.0%
Q4 2014$3,968,000182,3570.00%
Other shareholders
ONCOMED PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
BVF INC/IL 825,647$19,238,0003.04%
SECTORAL ASSET MANAGEMENT INC 1,392,485$32,445,0001.38%
SPHERA FUNDS MANAGEMENT LTD. 75,000$1,748,0000.43%
Eventide Asset Management 52,800$1,230,0000.17%
Alyeska Investment Group, L.P. 250,434$5,835,0000.13%
Convergence Investment Partners, LLC 28,715$669,0000.09%
COLUMBUS CIRCLE INVESTORS 253,348$5,903,0000.04%
QS BATTERYMARCH FINANCIAL MANAGEMENT, INC 66,800$1,557,0000.04%
Visium Asset Management, LP 75,001$1,748,0000.03%
Hodges Capital Management Inc. 15,000$349,0000.02%
View complete list of ONCOMED PHARMACEUTICALS INC shareholders